Clinical Trial Update: Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating oxytocin for social cognitive and functional deficits in schizophrenia (also applicable to schizoaffective disorder) has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED